Adelaide Research & Scholarship: Search

Search

Results 1-10 of 36 (Search time: 0.002 seconds).

previous
1
2
3
4
next

Item hits:

Preview	Issue Date	Title	Author(s)
	2002	High frequency of point mutations clustered within the adenosine triphosphate-binding region of BCR/ABL in patients with chronic myeloid leukemia or Ph-positive acute lymphoblastic leukemia who develop imatinib (STI571) resistance	Branford, S.; Rudzki, Z.; Walsh, S.; Grigg, A.; Arthur, C.; Taylor, K.; Herrmann, R.; Lynch, K.; Hughes, T.
	2020	Lineage of measurable residual disease in patients with chronic myeloid leukemia in treatment-free remission	Pagani, I.S.; Dang, P.; Saunders, V.A.; Grose, R.; Shanmuganathan, N.; Kok, C.H.; Carne, L.; Rwodzi, Z.; Watts, S.; McLean, J.; Braley, J.; Altamura, H.; Yeung, D.T.; Branford, S.; Yong, A.S.M.; White, D.L.; Hughes, T.P.; Ross, D.M.
	2022	Measurable residual disease in chronic myeloid leukemia.	Branford, S.; Apperley, J.F.
	2021	RUNX1 mutations in blast-phase chronic myeloid leukemia associate with distinct phenotypes, transcriptional profiles, and drug responses	Adnan Awad, S.; Dufva, O.; Ianevski, A.; Ghimire, B.; Koski, J.; Maliniemi, P.; Thomson, D.; Schreiber, A.; Heckman, C.A.; Koskenvesa, P.; Korhonen, M.; Porkka, K.; Branford, S.; Aittokallio, T.; Kankainen, M.; Mustjoki, S.
	2020	Aberrant RAG-mediated recombination contributes to multiple structural rearrangements in lymphoid blast crisis of chronic myeloid leukemia	Thomson, D.W.; Shahrin, N.H.; Wang, P.P.S.; Wadham, C.; Shanmuganathan, N.; Scott, H.S.; Dinger, M.E.; Hughes, T.P.; Schreiber, A.W.; Branford, S.
	2021	Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemia	Ochi, Y.; Yoshida, K.; Huang, Y.-J.; Kuo, M.-C.; Nannya, Y.; Sasaki, K.; Mitani, K.; Hosoya, N.; Hiramoto, N.; Ishikawa, T.; Branford, S.; Shanmuganathan, N.; Ohyashiki, K.; Takahashi, N.; Takaku, T.; Tsuchiya, S.; Kanemura, N.; Nakamura, N.; Ueda, Y.; Yoshihara, S.; et al.
	2019	Modeling the safe minimum frequency of molecular monitoring for CML patients attempting treatment-free remission	Shanmuganathan, N.; Braley, J.A.; Yong, A.S.M.; Hiwase, D.K.; Yeung, D.T.; Ross, D.M.; Hughes, T.P.; Branford, S.
	2023	Adverse outcomes for chronic myeloid leukemia patients with splenomegaly and low in vivo kinase inhibition on imatinib	Kok, C.H.; Saunders, V.A.; Dang, P.; Shanmuganathan, N.; White, D.; Branford, S.; Yeung, D.; Hughes, T.P.
	2023	Association of TIM-3 checkpoint receptor expression on T cells with treatment-free remission in chronic myeloid leukemia	Irani, Y.D.; Kok, C.H.; Clarson, J.; Shanmuganathan, N.; Branford, S.; Yeung, D.T.; Ross, D.M.; Hughes, T.P.; Yong, A.S.
	2022	RNA-Based Targeted Gene Sequencing Improves the Diagnostic Yield of Mutant Detection in Chronic Myeloid Leukemia.	Shanmuganathan, N.; Wadham, C.; Thomson, D.; Shahrin, N.H.; Vignaud, C.; Obourn, V.; Chaturvedi, S.; Yang, F.; Feng, J.; Saunders, V.; Kok, C.H.; Yeung, D.; King, R.M.; Kenyon, R.R.; Lin, M.; Wang, P.; Scott, H.; Hughes, T.; Schreiber, A.W.; Branford, S.